Xiang-Min Yang

2.4k total citations
33 papers, 899 citations indexed

About

Xiang-Min Yang is a scholar working on Molecular Biology, Immunology and Oncology. According to data from OpenAlex, Xiang-Min Yang has authored 33 papers receiving a total of 899 indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Molecular Biology, 16 papers in Immunology and 14 papers in Oncology. Recurrent topics in Xiang-Min Yang's work include Signaling Pathways in Disease (18 papers), Galectins and Cancer Biology (10 papers) and CAR-T cell therapy research (7 papers). Xiang-Min Yang is often cited by papers focused on Signaling Pathways in Disease (18 papers), Galectins and Cancer Biology (10 papers) and CAR-T cell therapy research (7 papers). Xiang-Min Yang collaborates with scholars based in China, United States and United Kingdom. Xiang-Min Yang's co-authors include Zhi‐Nan Chen, Jian‐Li Jiang, Fei Song, Jing Xu, Ping Zhu, Xiaoling Yu, Jinliang Xing, Huijie Bian, Rong Tian and Yang Zhang and has published in prestigious journals such as Journal of Biological Chemistry, Nature Communications and Molecular and Cellular Biology.

In The Last Decade

Xiang-Min Yang

32 papers receiving 895 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Xiang-Min Yang China	15	680	336	222	124	91	33	899
Tehila Ben-Moshe Israel	8	569 0.8×	361 1.1×	142 0.6×	104 0.8×	136 1.5×	11	793
Nektaria Simiantonaki Germany	13	296 0.4×	339 1.0×	476 2.1×	169 1.4×	60 0.7×	24	836
Saritha Kusam United States	11	350 0.5×	590 1.8×	193 0.9×	157 1.3×	143 1.6×	17	1.0k
Jérôme Mahiou United States	12	390 0.6×	408 1.2×	120 0.5×	157 1.3×	84 0.9×	15	925
Uta Schaefer Germany	8	513 0.8×	360 1.1×	201 0.9×	162 1.3×	98 1.1×	8	773
Esther P.M. Tjin Netherlands	19	497 0.7×	461 1.4×	284 1.3×	52 0.4×	77 0.8×	33	1.2k
Matteo Pallocca Italy	16	562 0.8×	146 0.4×	203 0.9×	277 2.2×	100 1.1×	36	852
Christine Wagner Austria	19	497 0.7×	391 1.2×	392 1.8×	111 0.9×	58 0.6×	41	1.0k
Galina M. Kiriakova United States	10	380 0.6×	169 0.5×	310 1.4×	210 1.7×	54 0.6×	11	707

Countries citing papers authored by Xiang-Min Yang

Since Specialization

Citations

This map shows the geographic impact of Xiang-Min Yang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiang-Min Yang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiang-Min Yang more than expected).

Fields of papers citing papers by Xiang-Min Yang

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiang-Min Yang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiang-Min Yang. The network helps show where Xiang-Min Yang may publish in the future.

Co-authorship network of co-authors of Xiang-Min Yang

This figure shows the co-authorship network connecting the top 25 collaborators of Xiang-Min Yang. A scholar is included among the top collaborators of Xiang-Min Yang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiang-Min Yang. Xiang-Min Yang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Zhang, Jiajia, Changgeng Song, Rui Liu, et al.. (2025). Lactate mitochondrial oxidation drives stemness potential in metastatic breast cancer. Nature Communications. 17(1). 399–399. 1 indexed citations

Shi, Ying, Xiang-Min Yang, Hongmei Zhang, et al.. (2025). An Anti‐CD147 Antibody−Drug Conjugate Mehozumab‐DM1 is Efficacious Against Hepatocellular Carcinoma in Cynomolgus Monkey. Advanced Science. 12(15). e2410438–e2410438. 2 indexed citations

Zhang, Jiajia, Changgeng Song, Miao Wang, et al.. (2023). Monoclonal antibody targeting mu-opioid receptor attenuates morphine tolerance via enhancing morphine-induced receptor endocytosis. Journal of Pharmaceutical Analysis. 13(10). 1135–1152. 7 indexed citations

Zheng, Ming, Yiming Li, Zhenyu Liu, et al.. (2022). Prognostic Landscape of Tumor-Infiltrating T and B Cells in Human Cancer. Frontiers in Immunology. 12. 731329–731329. 11 indexed citations

Xu, Jing, Xiaodong Wu, Hui Yao, et al.. (2020). CD147 regulates antitumor CD8+ T-cell responses to facilitate tumor-immune escape. Cellular and Molecular Immunology. 18(8). 1995–2009. 40 indexed citations

Guo, Na, Sheng Ye, Kui Zhang, et al.. (2018). A critical epitope in CD147 facilitates memory CD4+ T-cell hyper-activation in rheumatoid arthritis. Cellular and Molecular Immunology. 16(6). 568–579. 25 indexed citations

Wu, Bo, Jian Cui, Xiang-Min Yang, et al.. (2017). Cytoplasmic fragment of CD147 generated by regulated intramembrane proteolysis contributes to HCC by promoting autophagy. Cell Death and Disease. 8(7). e2925–e2925. 34 indexed citations

Geng, Jiejie, Juan Tang, Xiang-Min Yang, et al.. (2017). Targeting CD147 for T to NK Lineage Reprogramming and Tumor Therapy. EBioMedicine. 20. 98–108. 10 indexed citations

Wu, Bo, Yi Wang, Xiang-Min Yang, et al.. (2015). Basigin-mediated redistribution of CD98 promotes cell spreading and tumorigenicity in hepatocellular carcinoma. Journal of Experimental & Clinical Cancer Research. 34(1). 110–110. 33 indexed citations

10.

Li, Hongwei, Xiang-Min Yang, Juan Tang, et al.. (2014). Effects of HAb18G/CD147 Knockout on Hepatocellular Carcinoma Cells In Vitro Using a Novel Zinc-Finger Nuclease-Targeted Gene Knockout Approach. Cell Biochemistry and Biophysics. 71(2). 881–890. 6 indexed citations

11.

Wu, Jiao, Xiang-Min Yang, Hao Tang, et al.. (2014). Full-length soluble CD147 promotes MMP-2 expression and is a potential serological marker in detection of hepatocellular carcinoma. Journal of Translational Medicine. 12(1). 190–190. 37 indexed citations

12.

Hu, Jinsong, Hui Yao, Yu Li, et al.. (2010). Involvement of HAb18G/CD147 in T cell activation and immunological synapse formation. Journal of Cellular and Molecular Medicine. 14(8). 2132–2143. 28 indexed citations

13.

Wei, Jingjing, Xiang-Min Yang, Min Zheng, et al.. (2010). The recombinant chimeric antibody chHAb18 against hepatocellular carcinoma can be produced in milk of transgenic mice. Transgenic Research. 20(2). 321–330. 7 indexed citations

14.

Zhang, Zheng, Xiang-Min Yang, Hushan Yang, et al.. (2010). New strategy for large-scale preparation of the extracellular domain of tumor-associated antigen HAb18G/CD147 (HAb18GED). Journal of Bioscience and Bioengineering. 111(1). 1–6. 6 indexed citations

15.

Zhu, Hongbin, Bin Yang, Xiang-Min Yang, et al.. (2009). A novel antibody fragment targeting HAb18G/CD147 with cytotoxicity and decreased immunogenicity. Cancer Biology & Therapy. 8(11). 1035–1044. 12 indexed citations

16.

Yu, Xiaoling, Tiancen Hu, Jiamu Du, et al.. (2008). Crystal Structure of HAb18G/CD147. Journal of Biological Chemistry. 283(26). 18056–18065. 109 indexed citations

17.

Xu, Jing, Zhongyang Shen, Xinguo Chen, et al.. (2007). A randomized controlled trial of licartin for preventing hepatoma recurrence after liver transplantation. Hepatology. 45(2). 269–276. 150 indexed citations

18.

Liao, Cheng‐Gong, Yunming Li, Xiang-Min Yang, et al.. (2007). Epitope Mapping of Series of Monoclonal Antibodies Against the Hepatocellular Carcinoma‐associated Antigen HAb18G/CD147. Scandinavian Journal of Immunology. 65(5). 435–443. 31 indexed citations

19.

Wang, Li, Yu Li, Huijie Bian, et al.. (2006). Regulation of Matrix Metalloproteinase Production and Tumor Cell Invasion by Four Monoclonal Antibodies Against Different Epitopes of HAb18G/CD147 Extracellular Domain. Hybridoma. 25(2). 60–67. 11 indexed citations

20.

Yu, Li, et al.. (2005). Isolating human antibody against human hepatocellular carcinoma by guided-selection. Cancer Biology & Therapy. 4(12). 1374–1380. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact